PRISMA-the Preferred Reporting Items for Systematic Reviews and Meta-Analyses

 Source: http://www.prisma-statement.org/Default.aspx

Welcome to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) website! PRISMA is an evidence-based minimum set of items for reporting in systematic reviews and meta-analyses. PRISMA focuses on the reporting of reviews evaluating randomized trials, but can also be used as a basis for reporting systematic reviews of other types of research, particularly evaluations of interventions. Who should use PRISMA? Authors: PRISMA aims to help authors improve the reporting of systematic reviews and meta-analyses. Journal Peer reviewers and editors: PRISMA may also be useful for critical appraisal of published systematic reviews, although it is not a quality assessment instrument to gauge the quality of a systematic review. News Feed PRISMA Website re-design The PRISMA website underwent a much-needed update in October 2015 to update the content of the website. We have updated the look of the site and added the PRISMA extensions, translations, and information about review protocols. PRISMA Extensions! Several PRISMA extensions have been published in 2015 so far. PRISMA-P for developing review protocols was published in January 2015 in Systematic Reviews and the BMJ. PRISMA-IPD (individual patient data) was published in JAMA in April PRISMA-NMA (Network Meta-Analyses) was published in Annals of Internal Medicine in June These are in addition to the PRISMA Abstract and Equity extensions, all found on the PRISMA website, here. Read more...

Key Documents PRISMA Checklist PRISMA flow diagram PRISMA Statement PRISMA E&E

PRISMA